Existen diferencias farmacocinéticas y tiempos de despertar entre mujeres y hombres con anestesia total intravenosa


Autoria(s): Parada, Lina; Guerra, Carlos
Contribuinte(s)

Rodriguez-Leguizamon, Giovanni

Moron, Lina

Data(s)

05/06/2014

Resumo

Introducción: La anestesia total intravenosa (TIVA) es ampliamente usada y reportada en la literatura como técnica para disminuir la respuesta a la laringoscopia e intubación, en la inducción y mantenimiento de una adecuada anestesia, además de una mejor estabilidad hemodinámica y recuperación pos anestésica; sin embargo no existen un gran número de estudios que comparen el uso de TIVA, determinando si existen diferencias en el perfil farmacocinético según el género del paciente. Objetivo: Describir diferencias farmacocinéticas y de los tiempos de despertar y salida a la unidad de cuidados pos anestésicos (descarga), según el género; en pacientes que reciben TIVA, con remifentanil y propofol, orientado por Stangraf. Metodología: Estudio observacional analítico de corte transversal, en pacientes llevados a cirugía bajo TIVA en el Hospital Occidente de Kennedy en el periodo de junio de 2013 a Enero de 2014.Usando SPSS versión 20 Windows, se analizaron los datos mediante pruebas Kolmogorov-Smirnov y Shapiro-Wilk y U de Mann Withney. Un valor de p menor 0.05 fue aceptado como estadísticamente significativo. Resultados: Se aplicaron pruebas de normalidad y no se encontraron diferencias estadísticamente significativas entre género. El tiempo de despertar fue 9.36 minutos para mujeres y 11.26 minutos para hombres. Los tiempos de descarga fueron 10.71 minutos para mujeres y 12.82 minutos para hombres. Discusión. El tiempo de despertar y descarga no es diferente entre mujeres y hombres en los pacientes analizados. Se requieren estudios adicionales entre grupos poblacionales de diversas condiciones farmacocineticas para corroborar los datos.

INTRODUCTION: the total anesthesia intravenous (TIVA) is worldwide used and reported in literature like technical to decrease the answer to laryngoscopy and intubation in the induction and maintance in a suitable anesthesia, besides a better hemodinamic stability and recuperation post anesthesia: however there is not a great number of studies that compare the use of TIVA to determine if ther is a differences in the pharmacokinetic profile according to the kind of patient. OBJECTIVE: to describe pharmacokinetic differences and the wake up times and the departure trom the post anestesic take care unit (discharge) according to the kind, in patients that receive TIVA with remifentanil and propofol oriented by stangraf. METHODOLOGY: analitical observational studies of transversal cut in patients taken to surgery with TIVA in the hospital occidente de Kennedy in the time from June 2013 to January 2014 using SPSS version 20 windows the data was analyzed with the help of kolmogorof-smirnof and shapiro-wilk and U de Mann Whitney test. A value of p less 0.005 was accepted like statisticly significant. RESULTS: normality tests were made and there were not found statisticly significant differences between genders. The woken up time was 9.36 minutes for women and 11.26 minutes for men. The discharge time was 10.71 minutes for women and 12.82 minutes for men. DISCUSSION: the woken up time and the discharge time is not different between men and women in the patients that were analized. It is necessary to do aditional studies in in different population groups from diverse pharmacokinetics conditions to reinforce the data.

Formato

application/pdf

application/pdf

application/pdf

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/8348

Idioma(s)

spa

Publicador

Facultad de Medicina

Direitos

info:eu-repo/semantics/openAccess

Fonte

reponame:Repositorio Institucional EdocUR

instname:Universidad del Rosario

1. Singh Bajwa SJ, Bajwa SK, Kaur J, Comparison of two drug combinations in total intravenous anesthesia: Propofol-ketamine and propofol-fentanyl. Saudi J Anaesth.2010 May; 4(2):72-9.

2. Vanegas Saavedra A, Anestesia Intravenosa, 2 ed. Bogotá: Editorial Médica Internacional, 2008.

3. Mirakhur RK, Morgan M, Intravenous anesthesia: a step forward. Anesthesia. 1998 Apr;53 Suppl 1:1-3.

4. Lichtenbelt BJ, Mertens M, Vuyk J, Strategies to optimize propofol-opioid Anesthesia. Clin Pharmacokinetic. 2004;43(9):577-93.

5. Lentschener C, Ghimouz A, Bonnichon P, Pépion C, Gomola A, Ozier Y, Remifentanil-propofol vs. sufentanil-propofol: optimal combinations in clinical anesthesia. Act Anaesthesiol Scand.2003 Jan;47(1):84-9.

6. Beers R, Camporesi E, Remifentanil update: clinical science and utility. CNS Drugs. 2004;18(15):1085-104.

7. Schraag S, Mohl U, Hirsch M, Stolberg E, Georgieff M, Recovery from opioid anesthesia: the clinical implication of context-sensitive half-times. Anesth Analg. 1998 Jan; 86(1):184-90.

8. Russell D, Intravenous anesthesia: manual infusion schemes versus TCI systems. Anesthesia. 1998 Apr;53Suppl 1:42-5.

9. Guillén-Dolores Y, Lugo-Goitia G, Eficacia clínica de una regla de cálculo para la dosificación de propofol en comparación con diprofusor utilizando índice biespectral. Rev. Mex. Anest. 2009; 32(4): 214-222.

10. Leslie K, Clavisi O, Hargrove J, Target-controlled infusion versus manually-controlled infusion of propofol for general anesthesia or sedation in adults. Anesth Analg. 2008 Dec;107(6):2089.

11. Friesen RH, Veit AS, Archibald DJ, Campanini RS, A comparison of remifentanil and fentanyl for fast track pediatric cardiac anesthesia. Pediatric Anaesth. 2003 Feb;13(2):122-5.

12. Maltepe F, Kocaayan E, Ugurlu BS, Akdeniz B, Guneri S, Comparison of remifentanil and fentanyl in anesthesia for elective cardioversion. Anaesth Intensive Care. 2006 Jun;34(3):353-7.

13. Kovac AL, Summers KL, Comparison of remifentanil versus fentanyl general anesthesia for short outpatient urologic procedures. Signa vitae 2009; 4(2): 23 – 29.

14. Sizlan A, Göktac U, Özhan C, Özhan M Ö, Orhan ME, Comparison of remifentanil, alfentanil, and fentanyl co-administered with propofol to facilitate laryngeal mask insertion. Turk J MedSei2010; 40(1): 63-70.

15. KhampaseuthRasakham, Lee-Yuan Liu-Chen, Sex differences in kappa opioid pharmacology. Elsevier, Philadelphia, PA, United States, Life Sciences 88 (2011) 2–16.

16. Nunes CS, Antunes LM, et al, Remifentanil bolus and entropy values in awake and anaesthetized patients. Are there any gender differences?. Eur J Anaesthesiol 2006; 23: 305–10.

17. Ortolani O, Conti A, Sall B, et al, The recovery of Senegalese African blacksfrom intravenous anesthesia with propofol and remifentanil is slower than that of Caucasians. Anesth Analg 2001; 93:1222–1226.

18. Gan TJ, Glass PS, Sigl J, et al, Women emerge faster from general anesthesia with propofol/alfentanil/nitrous oxide faster than men. Anesthesiology, 1999; 90:1283–1287.

19. Daryn H. Moller and Peter S.A, Should a patient’s gender alter the anesthetic plan?. CurrOpinAnaesthesiol 16:379–383. # 2003

20. Vuyk J, Ostwouder CJ, Vletter A, et al, Gender differences in the pharmacokinetics of propofol during and after continuous infusion. Br J Anaesth 2001; 86:183–188.

21. Sherwin KB, Johnston J, Class CA, et al, Multivariate cluster analysis of a human hepatic cytochrome P450 database. Eur J Clin Pharmacology 2002; 58:559–562.

22. Zubieta J, Dannals RF, Frost JJ, Gender and age influences on mu-opioid receptor binding measured by PET. Am J Psychiatry 1999; 156:842–848.

23. Drover DR, Lemmens HJ, Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology 1998; 89:869–877

24. Dahan MD, Sarton E, Teppema L, Olievier C. Sex-related differences in the influence of morphine on ventilatory control in humans. Anesthesiology 1998; 88:903–913.

25. Ohtsuka H. Pharmacokinetics of fentanyl in Male and Female rats after intravenous administration. Arzneimittelforschung. 2007; 57(5): 260-3.

26. Mawhinney LJ. Gender – specific differences in the central nervous system´s response to anesthesia. Transl Stroke Res. 2013 Aug; 4(4): 462-75.

27. Perez D, Vanegas A. Comparison of emergence and discharge times between two manual total intravenous Anesthesia techniques: Remifentanil and Fentanyl. Rev Col Anest 2013. 41: 250 -6.

28. Cascone S. Pharmacokinetics of Remifentanil: a three-compartmental modeling approach. Transl Med Unisa. 2013 Sep 2;7: 18-22.

TEME

Palavras-Chave #Anestesia Total Intravenosa (TIVA) #Remifentanil #Propofol #Perfil farmacocinético #Remifentanil, Propofol
Tipo

info:eu-repo/semantics/bachelorThesis

info:eu-repo/semantics/acceptedVersion